IRIS - Res&Arch Institutional Research Information System - Research & Archive

RUGGERI, Loredana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.374
EU - Europa 2.129
AS - Asia 945
SA - Sud America 188
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 5.650
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.346
IE - Irlanda 430
SG - Singapore 370
IT - Italia 353
UA - Ucraina 315
SE - Svezia 280
HK - Hong Kong 279
RU - Federazione Russa 225
BR - Brasile 173
FI - Finlandia 168
DE - Germania 159
CN - Cina 137
VN - Vietnam 64
GB - Regno Unito 61
FR - Francia 22
NL - Olanda 19
BE - Belgio 18
KR - Corea 17
TR - Turchia 16
AT - Austria 15
CA - Canada 15
IN - India 14
CH - Svizzera 11
RO - Romania 11
CZ - Repubblica Ceca 10
IQ - Iraq 10
MX - Messico 10
PL - Polonia 9
BD - Bangladesh 8
GR - Grecia 8
LB - Libano 7
ZA - Sudafrica 7
AR - Argentina 6
UZ - Uzbekistan 6
LT - Lituania 5
ES - Italia 3
PH - Filippine 3
AU - Australia 2
BG - Bulgaria 2
BO - Bolivia 2
EC - Ecuador 2
EU - Europa 2
LV - Lettonia 2
MA - Marocco 2
PY - Paraguay 2
SA - Arabia Saudita 2
TW - Taiwan 2
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
CO - Colombia 1
EE - Estonia 1
GE - Georgia 1
HN - Honduras 1
ID - Indonesia 1
IL - Israele 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
VE - Venezuela 1
Totale 5.650
Salva come PNG Salva come JPEG
Città #
Chandler 443
Dublin 430
San Mateo 287
Singapore 280
Hong Kong 278
Boardman 156
Jacksonville 150
Perugia 144
Santa Clara 99
Medford 82
Princeton 82
Moscow 74
Munich 74
Altamura 71
Ann Arbor 70
Wilmington 65
Andover 63
Dong Ket 59
Lawrence 55
Helsinki 49
Beijing 48
Des Moines 30
Turku 29
Saint Petersburg 24
Ashburn 22
Woodbridge 21
Los Angeles 20
Norwalk 20
Redwood City 17
Shanghai 15
Brussels 14
The Dalles 14
Espoo 13
Foligno 13
Houston 13
New York 13
Rome 13
San Paolo di Civitate 13
Falkenstein 12
Seoul 12
São Paulo 11
Amsterdam 10
Izmir 10
Dallas 9
Brooklyn 8
Chicago 8
Redmond 8
Bologna 7
Brasília 7
Bucharest 7
San Francisco 7
Brno 6
Florence 6
Rio de Janeiro 6
Vienna 6
Ancona 5
Atlanta 5
Auburn Hills 5
Belo Horizonte 5
Boston 5
Columbus 5
Den Haag 5
Falls Church 5
London 5
Ottawa 5
Baghdad 4
Dearborn 4
Deruta 4
Frankfurt am Main 4
Montreal 4
Nuremberg 4
Philadelphia 4
Porto Alegre 4
San Diego 4
Seattle 4
Secaucus 4
Sorocaba 4
Stockholm 4
Volta Redonda 4
West Jordan 4
Zaventem 4
Aurora 3
Campinas 3
Catanduva 3
Mirano 3
Oklahoma City 3
Olomouc 3
Ourinhos 3
Padova 3
Phoenix 3
Piracicaba 3
Prata Di Pordenone 3
Warsaw 3
Bengaluru 2
Bupyeong-gu 2
Carapicuíba 2
Catania 2
Chiajna 2
Erbil 2
Espírito Santo do Pinhal 2
Totale 3.667
Salva come PNG Salva come JPEG
Nome #
Innate immunity against hematological malignancies 115
Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells 111
Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation 103
A novel mutation of indoleamine 2,3-dioxygenase 1 causes a rapid proteasomal degradation and compromises protein function 98
Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self. 97
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 92
Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo. 90
. G-CSF blocks IL-12 productin by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation. 89
G-CSF blocks IL-12 production by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation.. 89
Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation. 87
Addition of PBPCs to the marrow inoculum allows engraftment of mismatched T cell-depleted transplants for acute leukemia 85
Natural killer cell alloreactivity in allogeneic hematopoietic transplantation. 83
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse 82
"Designed" grafts for HLA-haploidentical stem cell transplantation. 81
Natural killer cells: biology and application in stem-cell transplantation 80
Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. 80
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. 79
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality 79
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 77
Early intrathecal infusion of everolimus restores cognitive function and mood in a murine model of Alzheimer's disease 77
Clinical impact of natural killer cell reconstitution after allogenic hematopoitic transplantation.Immunobiology working Party of the European Group for Blood and Marrow Transplantation 76
Preclinical characterization of 1-7F9,a novel human anti-KIR receptor therapeutic antibody that augments natural kille-mediated killing of tumor cells. 75
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 75
Donor activating KIR genes and control of infections after haploidentical haematopoietic transplantation 75
Haploidentical transplantation and natural killer cell recognition of missing self. 74
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants 74
Natural killer cell alloreactivity for leukemia therapy. 74
Immunotherapy with alloreactive natural killer cells in haploidentical haematopoietic transplantation. 73
How Adoptive Immunotherapy with Conventional T and Regulatory T Cells Exerts a Gvl Effect without GvHD, after Haploidentical Hematopoietic Transplantation 73
Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants 71
Optimizing a photoallodepletion protocol for adoptive immunotherapy after haploidentical SCT. 69
Cellular therapy: exploiting NK cell alloreactivity in transplantation 67
Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation 67
Alloreactive natural killer cells for the treatment of acute myeloid leukemia: From stem cell transplantation to adoptive immunotherapy 67
Haploidentical hematopoietic transplantation for the cure of leukemia: from its biology to clinical translation. 67
A revised NOTCH1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia 67
NCRs and DNAM-1 mediate NK cell recognition and iysis of human and mouse melanoma cell lines in vitro and in vivo 66
Enhancing Regulatory T Cell Function and Homing to the Gut to Improve graft-versus-host Disease Prevention after Adoptive Transfer in Allogeneic Hematopoietic Transplantation 65
Natural killer cell alloreactivity and haplo-identical hematopoietic transplantation. 65
Involvement of Cd44 Variant Isoforms In Hyaluronate Adhesion By Human Activated T-cells 65
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 65
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 65
CD44 signaling through p56lck involves lateral association with CD4 in human CD4+ T cells. 62
New mechanism of lymphoma-induced bone marrow aplasia 61
Role of Natural Killer Cell Alloreactivity in HLA-Mismatched Hematopoietic Stem Cell Transplantation 60
The Total Body Irradiation Schedule Affects Acute Leukemia Relapse After Matched T Cell–Depleted Hematopoietic Stem Cell Transplantation 60
Expansion of CD56-negative, CD16-positive, KIR-expressing natural killer cells after T cell-depleted haploidentical hematopoietic stem cell transplantation. 60
Clinical impact of natural killer cell reconstitution after allogeneic hematopoietic transplantation. 59
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 59
Natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation 58
Exploitation of alloreactive NK cells in adoptive immunotherapy of cancer. 58
Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants 57
Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells 57
The “ultimate” haploidentical transplantation for the elderly with high-risk acute myeloid leukemia 57
Natural killer cell allorecognition of missing self in allogenic hematopoietic transplantation :a tool for immunotherapy of leukemia. 56
Post-grafting granulocyte colony-stimulating factor administration impairs functional immune recovery in recipients of HLA haplotype-mismatched hematopoietic transplants 55
Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect 55
Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1. 55
Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor. 55
Transplantation for high-risk acute leukemia with high doses of T cell-depleted hematopoietic stem cells from haploidentical “three loci” incompatible donors. 54
Striking survival advange of bad-risk acute myeloid leukemia patients transplanted from haploidentical donors with KIR epitope incompatibility in the GVH direction 54
Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients. 53
Natural killer-cell KIR repertoire reconstitution after haploidentical SCT. 53
Identifying NK alloreactive donors for haploidentical hematopoietic stem cell transplantation 53
Natural Killer (NK)-Cell Function and Anti-Leukemic Activity of a Large Population of CD3+/CD8+ T Cells Expressing NK Receptors for MHC Class I after “Three-Loci” HLA-Incompatible Bone Marrow Transplantation 52
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants 52
Jack of all trades: thymosin α1 and its pleiotropy. 51
Larger size of donor alloreactive NK cell repertoire correlates with better response to NK cell immunotherapy in elderly acute myeloid leukemia patients 51
Thymosin Alfa 1 Administration Improves Immune Reconstitution and Decreases Infection-Related Mortality After HLA-Matched Sibling T Cell-Depleted Stem Cell Transplantation. 50
Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation. 50
NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation. 49
The impact of donor natural killer cell alloreactivity on allogeneic hematopoietic transplantation. 49
null 46
Treatment of high-risk acute leukemia with T-cell-depleted stem cell related donors with one fully mismatched HLA haplotype. 46
Natural killer cell alloreactivity in allogeneic hematopoietic transplantation. 45
A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect 44
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces non-relapse mortality 44
Killer-cell immunoglobulin-like receptors reactivity and outcome of stem cell transplant. 44
NK cells: a lesson from mismatched hematopoietic transplantation 42
Thymosin Alfa 1 Administration Improves Immune Reconstitution and Decreases Infection-Related Mortality After HLA-Matched Sibling T Cell-Depleted Stem Cell Transplantation. 42
Next generation HLA-haploidentical HSCT 41
A Novel t(5;7)(q31;q21)/CDK6::IL3 in Immature T-cell Acute Lymphoblastic Leukemia With IL3 Expression and Eosinophilia 40
CD44 signaling through p56lck involves lateral association with CD4 in human CD4+ T cells 39
CAR T cell-driven cerebrospinal fluid cytokine storm with confounding neurological picture in chemorefractory primary cardiac lymphoma 37
Blinatumomab Redirects Donor Lymphocytes against CD19+ Acute Lymphoblastic Leukemia without Relevant Bystander Alloreactivity after Haploidentical Hematopoietic Stem Cell Transplantation 36
null 36
Novel Immune Cell-Based Therapies to Eradicate High-Risk Acute Myeloid Leukemia 36
Natural killer cell-mediated lysis of autologous cells modified by gene therapy 35
Natural killer cells as a therapeutic tool in mismatched transplantation 35
Polatuzumab‐bendamustine‐rituximab as bridge to CD19‐directed CAR T cells in mantle cell lymphoma refractory to ibrutinib and venetoclax 33
Impact of total marrow/lymphoid irradiation dose to the intestine on graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for hematologic malignancies 32
Natural killer (NK)-cell function and antileukemic activity of a large population of CD3+/CD8+ T cells expressing NK receptors for major histocompatibility complex class I after "three-loci" HLA-incompatible bone marrow transplantation 32
Natural killer cell activity and killer immunoglobulin-like receptors in hematopoietic stem cell transplantation 28
null 27
How adoptive transfer of components of the donor immune system boosts GvL and prevents GvHD in HLA-haploidentical hematopoietic transplantation for acute leukemia 21
Donor natural killer cells trigger production of beta-2-microglobulin to enhance post bone marrow transplant immunity 14
null 11
Totale 5.850
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.626
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.626
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021685 9 59 25 53 203 55 46 7 73 24 56 75
2021/2022873 14 235 29 51 45 5 6 231 10 36 101 110
2022/20231.394 91 258 15 108 97 150 4 67 524 8 53 19
2023/2024652 40 78 24 8 3 9 173 14 61 21 112 109
2024/20251.380 23 136 34 89 199 60 51 119 235 71 216 147
2025/202689 89 0 0 0 0 0 0 0 0 0 0 0
Totale 5.850